Haleon PLC Director Acquires Shares, Signaling Confidence in Market Position
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Morgan Stanley Upgrades Haleon(HLN.US) to Buy Rating, Raises Target Price to $11.25
Morgan Stanley Upgrades Haleon to Overweight From Equalweight, Adjusts Price Target to $11.25 From $10.65
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and Haleon PLC Sponsored ADR (HLN)
